2017
Zhou Y, Cai M. 2017. Novel approaches to the design of bioavailable melanotropins. Expert Opin Drug Discov. 12:1023–1030. doi:10.1080/17460441.2017.1351940.
Chalasani P. 2017. Optimizing Quality of Life in Patients with Hormone Receptor-Positive Metastatic Breast Cancer: Treatment Options and Considerations. Oncology. 93:143–156. doi:10.1159/000477404.
Van Doorslaer K, Chen D, Chapman S, Khan J, McBride AA. 2017. Persistence of an Oncogenic Papillomavirus Genome Requires Elements from the Viral Transcriptional Enhancer. mBio. 8. doi:10.1128/mBio.01758-17.
Eckert R, Huberty J, Gowin K, Mesa R, Marks L. 2017. Physical Activity as a Nonpharmacological Symptom Management Approach in Myeloproliferative Neoplasms: Recommendations for Future Research. Integr Cancer Ther. 16:439–450. doi:10.1177/1534735416661417.
Driscoll LJ, Brown HE, Harris RB, Oren E. 2017. Population Knowledge, Attitude, and Practice Regarding Transmission and Outcomes: A Literature Review. Front Public Health. 5:144. doi:10.3389/fpubh.2017.00144.
Richards Z, Batai K, Farhat R, Shah E, Makowski A, Gann PH, Kittles R, Nonn L. 2017. Prostatic compensation of the vitamin D axis in African American men. JCI Insight. 2:e91054. doi:10.1172/jci.insight.91054.
Einspahr JG, Curiel-Lewandrowski C, Calvert VS, Stratton SP, Alberts DS, Warneke J, Hu C, Saboda K, Wagener EL, Dickinson S, et al. 2017. Protein activation mapping of human sun-protected epidermis after an acute dose of erythemic solar simulated light. NPJ Precis Oncol. 1. doi:10.1038/s41698-017-0037-7.
Batai K, Murphy AB, Ruden M, Newsome J, Shah E, Dixon MA, Jacobs ET, Hollowell CMP, Ahaghotu C, Kittles RA. 2017. Race and BMI modify associations of calcium and vitamin D intake with prostate cancer. BMC Cancer. 17:64. doi:10.1186/s12885-017-3060-8.
Dalton HJ, Farley JH. 2017. Racial disparities in cervical cancer: Worse than we thought. Cancer. 123:915–916. doi:10.1002/cncr.30501.
Gupta S, Jacobs ET, Baron JA, Lieberman DA, Murphy G, Ladabaum U, Cross AJ, Jover R, Liu L, Martinez ME. 2017. Risk stratification of individuals with low-risk colorectal adenomas using clinical characteristics: a pooled analysis. Gut. 66:446–453. doi:10.1136/gutjnl-2015-310196.
Ambrose AJ, Santos EA, Jimenez PC, Rocha DD, Wilke DV, Beuzer P, Axelrod J, Kumar Kanduluru A, Fuchs PL, Cang H, et al. 2017. Ritterostatin G 1 , a Cephalostatin-Ritterazine Bis-steroidal Pyrazine Hybrid, Selectively Targets GRP78. Chembiochem. 18:506–510. doi:10.1002/cbic.201600669.
Gonzalez VJ. 2017. Role of Radiation Therapy in the Treatment of Hodgkin Lymphoma. Curr Hematol Malig Rep. 12:244–250. doi:10.1007/s11899-017-0385-y.
Kunyansky L, Ingram CP, Witte RS. 2017. Rotational magneto-acousto-electric tomography (MAET): theory and experimental validation. Phys Med Biol. 62:3025–3050. doi:10.1088/1361-6560/aa6222.
Weinstein RS, Waer AL, Weinstein JB, Briehl MM, Holcomb MJ, Erps KA, Holtrust AL, Tomkins JM, Barker GP, Krupinski EA. 2017. Second Flexner Century: The Democratization of Medical Knowledge: Repurposing a General Pathology Course Into Multigrade-Level "Gateway" Courses. Acad Pathol. 4:2374289517718872. doi:10.1177/2374289517718872.
Colletti SM, Tranesh GA, Nassar A. 2017. Significance of finding benign endometrial cells in women 40-45 versus 46 years or older on Papanicolaou tests and histologic follow-up. Cytojournal. 14:22. doi:10.4103/cytojournal.cytojournal_16_17.
Kendrick S, Muranyi A, Gokhale V, Hurley LH, Rimsza LM. 2017. Simultaneous Drug Targeting of the Promoter MYC G-Quadruplex and BCL2 i-Motif in Diffuse Large B-Cell Lymphoma Delays Tumor Growth. J Med Chem. 60:6587–6597. doi:10.1021/acs.jmedchem.7b00298.
Gestaut MM, Thawani N, Kim S, Gutti VR, Jhavar S, Deb N, Morrow A, Ward RA, Huang JH, Patel M. 2017. Single fraction spine stereotactic ablative body radiotherapy with volumetric modulated arc therapy. J Neurooncol. 133:165–172. doi:10.1007/s11060-017-2428-6.
Cai M, Marelli UK, Mertz B, Beck JG, Opperer F, Rechenmacher F, Kessler H, Hruby VJ. 2017. Structural Insights into Selective Ligand-Receptor Interactions Leading to Receptor Inactivation Utilizing Selective Melanocortin 3 Receptor Antagonists. Biochemistry. 56:4201–4209. doi:10.1021/acs.biochem.7b00407.
Brown RV, Wang T, Chappeta VR, Wu G, Onel B, Chawla R, Quijada H, Camp SM, Chiang ET, Lassiter QR, et al. 2017. The Consequences of Overlapping G-Quadruplexes and i-Motifs in the Platelet-Derived Growth Factor Receptor β Core Promoter Nuclease Hypersensitive Element Can Explain the Unexpected Effects of Mutations and Provide Opportunities for Selective Targeting. J Am Chem Soc. 139:7456–7475. doi:10.1021/jacs.6b10028.
Van Doorslaer K, Li Z, Xirasagar S, Maes P, Kaminsky D, Liou D, Sun Q, Kaur R, Huyen Y, McBride AA. 2017. The Papillomavirus Episteme: a major update to the papillomavirus sequence database. Nucleic Acids Res. 45:D499-D506. doi:10.1093/nar/gkw879.
Fakhry C, Westra WH, Wang SJ, van Zante A, Zhang Y, Rettig E, Yin LX, Ryan WR, Ha PK, Wentz A, et al. 2017. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer. Cancer. 123:1566–1575. doi:10.1002/cncr.30353.
Hogan NT, Whalen MB, Stolze LK, Hadeli NK, Lam MT, Springstead JR, Glass CK, Romanoski CE. 2017. Transcriptional networks specifying homeostatic and inflammatory programs of gene expression in human aortic endothelial cells. Elife. 6. doi:10.7554/eLife.22536.
Dewhirst MW, Secomb TW. 2017. Transport of drugs from blood vessels to tumour tissue. Nat Rev Cancer. 17:738–750. doi:10.1038/nrc.2017.93.
Knatko EV, Praslicka B, Higgins M, Evans A, Purdie KJ, Harwood CA, Proby CM, Ooi A, Dinkova-Kostova AT. 2017. Whole-Exome Sequencing Validates a Preclinical Mouse Model for the Prevention and Treatment of Cutaneous Squamous Cell Carcinoma. Cancer Prev Res (Phila). 10:67–75. doi:10.1158/1940-6207.CAPR-16-0218.